Re: ZHCLF up 290% to $0.16...question
in response to
by
...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Message: Re: ZHCLF up 290% to $0.16...question
Correction :
MarketWatch lists ZHCLF as having shares outstanding 134.99M. Not Stockwatch.
NOW ON BMO:
| ZHCLF(ZENITH CAP CORP) | Real-time | ||
|
$0.40
|
Bid:
$0.00
|
Ask:
|
$0.00
|
|
|
Bid Lots:
0
|
Ask Lots:
|
0
|
|
|
High:
$0.40
|
Low:
|
$0.16
|
|
Last trade:
|
Vol:
50,476
|
Tick:
|
+
|
|
13:38 ET
|
Koo
New Message
Please
login
to post a reply